Veeva Vault CRM Selected by Eli Lilly and Company

This is an announcement that Eli Lilly has committed to implementing Veeva Vault CRM globally, as part of Veeva's Vault CRM Suite supporting what the page calls 'agentic commercial,' an AI-driven commercial model. Giuseppe Firenze, Lilly's senior vice president, is quoted saying the platform will help deliver breakthrough medicines to more patients. Veeva CEO Peter Gassner comments on expanding the strategic partnership through this rollout. As a selection announcement, it contains no implementation outcomes or metrics.

Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.